|
Market Cap (6-Jun) $15,812,900 (1,318th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 2,106,389 |
Shortsold (23-Jan) 143,231 (0.01%) (538th) |
|
52w High $0.029 |
52w Low $0.010 |
P/E - |
EPS 0 |
NTI released this announcement to the ASX on 22 June 2022, 10:40. The announcement is not marked as price sensitive, and is 17 page(s) in length and 6.56MB in size.
You can view all announcements from NTI and see how they appear on a price chart on the announcements page.
At the date of this announcement, NTI was 0.086% short sold according to ASIC data. It was ranked the 486th most shorted stock on the ASX. It remains ranked 538th as of the latest reported data (23 January 2026).
| Other Recent Announcements from NTI | |
|---|---|
| Notification of cessation of securities - NTI | 30 June 2023, 17:06 |
| Notification regarding unquoted securities - NTI | 28 June 2023, 16:14 |
| NTI to Present at Rett Syndrome Foundation Meeting | 5 June 2023, 8:27 |
| Neurotech CEO to Present at Gold Coast Investment Showcase | 22 June 2022, 10:40 |
| Proposed issue of securities - NTI | 9 June 2022, 11:13 |
| Preclinical Success with Targeted Combination Therapies | 9 June 2022, 10:56 |
| Investor Webinar Presentation | 3 June 2022, 8:37 |
You must be logged in to post a reply.
Neurotech International 